483
Reproductive Technologies, Inc.FDA 483 - Reproductive Technologies, Inc. - November 18, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Reproductive Technologies, Inc. in Berkeley, CA, from November 14-18, 2024, revealed a significant deficiency in donor eligibility determination. The firm failed to properly screen and test HCT/P donors, specifically distributing semen from a donor who reported extensive travel to the UK during a period associated with CJD risk. This indicates a serious lapse in donor screening protocols.
- Person
Open in Dashboard
ID · 17dd402d-e532-4072-8270-7fee3c51c869